{"id":1212349,"date":"2023-12-14T17:57:07","date_gmt":"2023-12-14T22:57:07","guid":{"rendered":"https:\/\/www.prime-wow.com\/?p=1212349"},"modified":"2023-12-14T17:57:07","modified_gmt":"2023-12-14T22:57:07","slug":"mdma-aka-ecstasy-submitted-to-fda-as-part-of-ptsd-therapy","status":"publish","type":"post","link":"https:\/\/www.prime-wow.com\/?p=1212349","title":{"rendered":"MDMA\u2014aka ecstasy\u2014submitted to FDA as part of PTSD therapy"},"content":{"rendered":"<div id=\"rss-wrap\">\n<figure class=\"intro-image intro-left\">\n  <img decoding=\"async\" src=\"https:\/\/www.prime-wow.com\/wp-content\/uploads\/2023\/12\/GettyImages-129369291-800x600-1.jpg\" alt=\"Girl with an ecstasy tablet on her tongue.\" \/><\/p>\n<p class=\"caption\" style=\"font-size:0.8em\"><a href=\"https:\/\/cdn.arstechnica.net\/wp-content\/uploads\/2016\/11\/GettyImages-129369291.jpg\" class=\"enlarge-link\" data-height=\"3750\" data-width=\"5000\">Enlarge<\/a> <span class=\"sep\">\/<\/span> Girl with an ecstasy tablet on her tongue. (credit: <a rel=\"nofollow\" class=\"caption-link\" href=\"http:\/\/www.gettyimages.com\/license\/129369291\">Getty | UniversalImagesGroup<\/a>)<\/p>\n<\/figure>\n<div><a name=\"page-1\" \/><\/div>\n<p>A corporation dedicated to studying the benefits of psychedelic drugs filed an application with the Food and Drug Administration this week for approval to use MDMA\u2014aka ecstasy or molly\u2014in combination with talk therapy to treat post-traumatic stress disorder.<\/p>\n<p>If approved, it would be the first-of-its-kind combination treatment\u2014a psychedelic-assisted therapy. An approval would also require the Drug Enforcement Administration to reclassify MDMA, which is currently in the DEA&#8217;s most restricted category, Schedule I, which is defined as drugs &#8220;with no currently accepted medical use and a high potential for abuse.&#8221; The category also includes LSD, heroin, and marijuana.<\/p>\n<p>The public benefit corporation (PBC) that filed the FDA application was created by MAPS, The Multidisciplinary Association for Psychedelic Studies, which has been supporting this type of work since 1986. The application is based on positive data from two randomized, double-blind, placebo-controlled Phase III studies, which were funded and organized by MAPS and MAPS PBC.<\/p>\n<\/div>\n<p><a href=\"https:\/\/arstechnica.com\/?p=1991296#p3\">Read 8 remaining paragraphs<\/a> | <a href=\"https:\/\/arstechnica.com\/?p=1991296&amp;comments=1\">Comments<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nSource: Ars Technica &#8211; <a href=\"https:\/\/arstechnica.com\/?p=1991296\" target=\"_blank\" rel=\"noopener\">MDMA\u2014aka ecstasy\u2014submitted to FDA as part of PTSD therapy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Enlarge \/ Girl with an ecstasy tablet on her tongue. (credit: Getty | UniversalImagesGroup) A corporation dedicated to studying the benefits of psychedelic drugs filed an application with the Food and Drug Administration this week for approval to use MDMA\u2014aka &hellip; <a href=\"https:\/\/www.prime-wow.com\/?p=1212349\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1212350,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[27,110],"tags":[73],"class_list":["post-1212349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ars-technica","category-unfiltered-rss","tag-ars-technica"],"_links":{"self":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1212349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1212349"}],"version-history":[{"count":0,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1212349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/media\/1212350"}],"wp:attachment":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1212349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1212349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1212349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}